Medical Devices

Home > Medical Devices
  • All
  • Healthcare
  • Life Sciences
  • Medical Devices
November 12, 2020

Abbott revenues increased by 9.6% to $8.85bn in Q3FY20. The increase was driven by an increase in the Diagnostics segment as a result of demand for Abbott’s portfolio of COVID 19 diagnostics tests on its lab based immunoassay and molecular diagnostics systems and point of care rapid testing platforms. Sales growth in Medical Devices and […]

Read more
November 6, 2020

The company launched innovative Thermo Scientific products across businesses, highlighted by two Selectris imaging filters for cryo-electron microscopes that accelerate research in structural analysis of proteins, and the POROS Oligo (dT)25 Affinity Resin to advance mRNA-based therapies and vaccines. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

Read more
October 31, 2020

Medtronic plc | is experiencing the benefit of new product launches as pipeline kicks in across the company. They had over 130 regulatory approvals this calendar year in the US, Europe, Japan, and China. Procedure volumes began to recover this quarter in multiple markets around the world, and drove market share gains in a number […]

Read more
October 9, 2020

Becton, Dickinson and Co launched four new products in the quarter and remain on track to deliver robust innovation pipeline for the year. It launched an upgrade to the BD FACS Melody to expand from 2-way sorting to 4-way sorting, enabling customers to capture more cell types. Executive Summary Financial Statements – Income Statement and […]

Read more
September 30, 2020

Boston Scientific Corporation| will be launching LUX-Dx implantable cardiac monitor, which will offer a seamless patient interface and back-end monitoring. It will have the ability to be programmed remotely and have event detection settings adjusted without an in person visit. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow […]

Read more
September 22, 2020

Life Sciences Solutions Segment revenue increased by 52.16% to $2.6bn in Q2FY20 due to increased sales of genetic sciences products, driven primarily by tests for diagnosis of COVID-19. Sales grew, to a lesser extent, due to higher demand for biosciences and bio-production products. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet […]

Read more
August 26, 2020

Abbott announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of the company’s Patient Controller app on compatible personal Apple smartphone devices. At Abbott, this approval allows patients living with neurological conditions, including chronic pain or movement disorders, the ability to manage therapy directly from their personal smartphone. […]

Read more
August 18, 2020

Medtronic plc, the global leader in medical technology, introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump customers in the United States. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps1. […]

Read more
July 31, 2020

Becton, Dickinson and Company completed the acquisition of Straub Medical, which will further expands the company’s portfolio with a proven device with that’s approved with dual indications for arterial atherectomy and thrombectomy in the U.S. It has solid existing sales in Europe and China. The company is leveraging their strong existing channel and expertise in […]

Read more
June 8, 2020

Boston Scientific announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device for patients with nonvalvular atrial fibrillation (NVAF). Presented as a late-breaking clinical trial at HRS 2020 SCIENCE, the study evaluated performance of the WATCHMAN FLX device as […]

Read more
June 2, 2020

Abbott recently launched three diagnostics tests for COVID 19, including molecular tests on its ID NOW™ rapid point of care platform and m 2000 RealTime lab based platform, and a serology blood test for the detection of the antibody, IgG, on its lab based immunoassay platforms. Organic sales growth in the quarter was led by strong […]

Read more
October 17, 2019

Medtronic’s revenues increased by 2% to $30.56bn for FY19, which was below our guidance of $31.15bn for FY19. Revenues in Q4FY19 increased by $2mn to $8.14bn which adjusts for a $289mn negative impact from foreign currency No. of Pages – 44 Contents Executive Summary Financial Statements –Income Statement and Forecast –Balance Sheet –Cash Flow –Q4FY19 […]

Read more
June 19, 2019

TMO completed the acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for ~$1.7bn in cash. Brammer will become part of TMO’s Pharma Services business within its Laboratory Products and Services Segment. This acquisition will boost growth for the company and therefore, we expect 4% growth in revenues in […]

Read more
June 11, 2019

Abbott delivered strong Q1FY19 performance with 2% growth in revenues on reported basis and 7.1% growth in revenues on an organic basis. The growth was due to double-digit growth in FreeStyle Libre, MitraClip and Alinity. The adjusted EPS grew by 6.8% to $0.63 in Q1FY19 Number of pages – 41 Content: Executive Summary………………………………………………………..1 Financial Statements […]

Read more
Load more